Caspases and therapeutic potential of caspase inhibitors in moderate‐severe SARS CoV2 infection and long COVID.

Added 370 days ago (16.05.2021)
Authors: Matthew Plassmeyer, Oral Alpan, Michael J. Corley, Thomas A. Premeaux, Kimberleigh Lillard, Paige Coatney, Tina Vaziri, Suzan Michalsky, Alina P.S. Pang, Zaheer Bukhari, Stephen T. Yeung, Teresa H. Evering, Gail Naughton, Martin Latterich, Philip Mudd, Alfred Spada, Nicole Rindone, Denise Loizou, Søren Ulrik Sønder, Lishomwa C. Ndhlovu, Raavi Gupta
Journal: Allergy
Read article